Literature DB >> 2681436

Cross-reactivity of monoclonal antibodies to Escherichia coli J5 with heterologous gram-negative bacteria and extracted lipopolysaccharides.

M K Aydintug1, T J Inzana, T Letonja, W C Davis, L B Corbeil.   

Abstract

A panel of eight murine monoclonal antibodies (MAbs) were produced against heat-killed Escherichia coli J5 and shown to react with J5 lipopolysaccharide (LPS) by enzyme-linked immunosorbent assay (ELISA). These antibodies were then assayed by a suspension ELISA for reactivity with up to 20 heterologous smooth or rough isolates of gram-negative bacteria, which were assayed after heat or formalin treatment, or as live cells. Extracted LPS from the same bacteria were tested for reactivity with the MAbs by direct ELISA. The MAbs demonstrated broad cross-reactivity with most heat-treated bacteria. In contrast, cross-reactivity of the MAbs with live or formalin-treated bacteria was limited almost exclusively to E. coli J5, Hemophilus species, or rough mutants of Salmonella minnesota. Reactivity with extracted LPSs and lipid A varied considerably depending on the MAb. Further, when Western blotting was used as the assay only four of eight MAbs reacted with J5 LPS, and none of the MAbs reacted with LPS from smooth S. minnesota or any of its rough mutants. Adsorption of the MAbs with acid hydrolyzed, boiled, or live E. coli J5 prior to ELISA of the MAbs with J5 LPS supported evidence that none of the MAbs were specific for lipid A and that reactivity was greater with boiled than with live cells. Thus, the cross-reactivity of antibodies to E. coli J5 LPS is dependent on the physical state of the bacteria or LPS used for assay, the assay used, and the specificity of the antibody.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2681436     DOI: 10.1093/infdis/160.5.846

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Long-term in vivo depletion of functional CD4+ T lymphocytes from calves requires both thymectomy and anti-CD4 monoclonal antibody treatment.

Authors:  R A Valdez; T C McGuire; W C Brown; W C Davis; D P Knowles
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

Review 2.  Immunoprophylaxis and immunotherapy of gram-negative sepsis and shock with antibodies to core glycolipids and lipid A of bacterial lipopolysaccharides.

Authors:  I G Mitov; D G Terziiski
Journal:  Infection       Date:  1991 Nov-Dec       Impact factor: 3.553

3.  Antibiotics enhance binding by human lipid A-reactive monoclonal antibody HA-1A to smooth gram-negative bacteria.

Authors:  S A Siegel; M E Evans; M Pollack; A O Leone; C S Kinney; S H Tam; P E Daddona
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

4.  Identification and characterization of a DNA region involved in the export of capsular polysaccharide by Actinobacillus pleuropneumoniae serotype 5a.

Authors:  C K Ward; T J Inzana
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

5.  Phenotypic phase variation in Haemophilus somnus lipooligosaccharide during bovine pneumonia and after in vitro passage.

Authors:  T J Inzana; R P Gogolewski; L B Corbeil
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

6.  Selective in vivo depletion of CD4(+) T lymphocytes with anti-CD4 monoclonal antibody during acute infection of calves with Anaplasma marginale.

Authors:  Reginald A Valdez; Travis C McGuire; Wendy C Brown; William C Davis; Jeffrey M Jordan; Donald P Knowles
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

7.  Conservation of the lipooligosaccharide synthesis locus lgt among strains of Neisseria gonorrhoeae: requirement for lgtE in synthesis of the 2C7 epitope and of the beta chain of strain 15253.

Authors:  A L Erwin; P A Haynes; P A Rice; E C Gotschlich
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

8.  A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides.

Authors:  F E Di Padova; H Brade; G R Barclay; I R Poxton; E Liehl; E Schuetze; H P Kocher; G Ramsay; M H Schreier; D B McClelland
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

9.  Synthesis in Escherichia coli of two smaller enzymically active analogues of Coxiella burnetii macrophage infectivity potentiator (CbMip) protein utilizing a single open reading frame from the cbmip gene.

Authors:  Y Y Mo; J Seshu; D Wang; L P Mallavia
Journal:  Biochem J       Date:  1998-10-01       Impact factor: 3.857

10.  Immunopathology of chronic lentivirus-induced arthritis.

Authors:  M J Wilkerson; W C Davis; T V Baszler; W P Cheevers
Journal:  Am J Pathol       Date:  1995-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.